First Tracks Biotherapeutics Statistics
NASDAQ: TRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
30.59-0.80 (-2.55%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
First Tracks Biotherapeutics by the numbers
First Tracks Biotherapeutics has a market capitalization of $1.09 billion based on 35.73M shares outstanding. With trailing EPS of $-4.71, First Tracks Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.7% below its 50-day average and 4.2% above its 200-day average.
Average daily trading volume is 788.93K shares, or about $24.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TRAX valuation vs. peer median
| Metric | TRAX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.09B | $1.10B | -1% |
| Avg. volume | 788.93K | 581.06K | +36% |
Peer median across 8 companies: AVLN, MNKD, LBRX, JANX, HROW, BCAX, AMPH, OPK.
Valuation
- Market cap
- $1.09B
- EPS (TTM)
- $-4.71
- Shares outstanding
- 35.73M
Price and trading
- Previous close
- 31.39
- Open
- 30.91
- Day range
- 30.53 – 31.75
- 52-week range
- 14.72 – 49.91
- Beta
- —
- Volume
- 354.99K
- Average volume
- 788.93K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.09B
- Forward Pe
- -8.54
- Eps
- -4.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 49.91
- Week52 Low
- 14.72
- Avg Volume
- 788.93K
- Shares Outstanding
- 35.73M
- Ma50
- 41.16
- Ma200
- 29.36
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -38.71%
- Pct From52w Low
- 107.81%